Intensive Phosphate Control in Development of Renal End Points and Mortality in CKD (the IPeR Study)

Trial Profile

Intensive Phosphate Control in Development of Renal End Points and Mortality in CKD (the IPeR Study)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Jun 2014

At a glance

  • Drugs Calcium acetate (Primary)
  • Indications Renal failure
  • Focus Therapeutic Use
  • Acronyms IPeR
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top